Vanguard Group’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $18.3M | Sell |
934,316
-134,716
| -13% | -$2.79M | ﹤0.01% | 2652 |
|
|
2025
Q3 | $29.5M | Buy |
1,069,032
+57,249
| +6% | +$1.76M | ﹤0.01% | 2432 |
|
|
2025
Q2 | $30.9M | Sell |
1,011,783
-362,125
| -26% | -$10.3M | ﹤0.01% | 2352 |
|
|
2025
Q1 | $37.1M | Sell |
1,373,908
-172,782
| -11% | -$5.47M | ﹤0.01% | 2226 |
|
|
2024
Q4 | $55.5M | Sell |
1,546,690
-55,795
| -3% | -$2.09M | ﹤0.01% | 2120 |
|
|
2024
Q3 | $60.8M | Buy |
1,602,485
+27,549
| +2% | +$1.13M | ﹤0.01% | 2093 |
|
|
2024
Q2 | $71.3M | Sell |
1,574,936
-6,756
| -0.4% | -$311K | ﹤0.01% | 2004 |
|
|
2024
Q1 | $76.7M | Sell |
1,581,692
-1,050
| -0.1% | -$51.4K | ﹤0.01% | 1991 |
|
|
2023
Q4 | $84.8M | Buy |
1,582,742
+15,560
| +1% | +$787K | ﹤0.01% | 1945 |
|
|
2023
Q3 | $91.9M | Buy |
1,567,182
+38,533
| +3% | +$2.41M | ﹤0.01% | 1850 |
|
|
2023
Q2 | $96.4M | Sell |
1,528,649
-14,305
| -0.9% | -$911K | ﹤0.01% | 1876 |
|
|
2023
Q1 | $97.1M | Buy |
1,542,954
+8,044
| +0.5% | +$480K | ﹤0.01% | 1847 |
|
|
2022
Q4 | $81.7M | Buy |
1,534,910
+54,227
| +4% | +$2.94M | ﹤0.01% | 1917 |
|
|
2022
Q3 | $83M | Sell |
1,480,683
-16,700
| -1% | -$1.1M | ﹤0.01% | 1910 |
|
|
2022
Q2 | $108M | Sell |
1,497,383
-13,469
| -0.9% | -$1M | ﹤0.01% | 1771 |
|
|
2022
Q1 | $120M | Buy |
1,510,852
+12,121
| +0.8% | +$1.09M | ﹤0.01% | 1841 |
|
|
2021
Q4 | $152M | Sell |
1,498,731
-34,577
| -2% | -$3.45M | ﹤0.01% | 1757 |
|
|
2021
Q3 | $141M | Buy |
1,533,308
+41,449
| +3% | +$3.99M | ﹤0.01% | 1789 |
|
|
2021
Q2 | $153M | Sell |
1,491,859
-3,154
| -0.2% | -$317K | ﹤0.01% | 1772 |
|
|
2021
Q1 | $146M | Buy |
1,495,013
+67,353
| +5% | +$6.13M | ﹤0.01% | 1750 |
|
|
2020
Q4 | $110M | Buy |
1,427,660
+34,466
| +2% | +$2.67M | ﹤0.01% | 1785 |
|
|
2020
Q3 | $103M | Buy |
1,393,194
+35,259
| +3% | +$2.83M | ﹤0.01% | 1677 |
|
|
2020
Q2 | $99.7M | Sell |
1,357,935
-35,413
| -3% | -$2.78M | ﹤0.01% | 1678 |
|
|
2020
Q1 | $80.5M | Buy |
1,393,348
+55,423
| +4% | +$3.85M | ﹤0.01% | 1649 |
|
|
2019
Q4 | $105M | Sell |
1,337,925
-366
| -0% | -$27K | ﹤0.01% | 1725 |
|
|
2019
Q3 | $91.5M | Sell |
1,338,291
-97,577
| -7% | -$6.55M | ﹤0.01% | 1777 |
|
|
2019
Q2 | $114M | Sell |
1,435,868
-28,349
| -2% | -$2.25M | ﹤0.01% | 1679 |
|
|
2019
Q1 | $123M | Buy |
1,464,217
+112,761
| +8% | +$11.8M | ﹤0.01% | 1641 |
|
|
2018
Q4 | $159M | Buy |
1,351,456
+105,649
| +8% | +$12.2M | 0.01% | 1393 |
|
|
2018
Q3 | $150M | Buy |
1,245,807
+120,709
| +11% | +$15M | 0.01% | 1580 |
|
|
2018
Q2 | $130M | Buy |
1,125,098
+91,484
| +9% | +$10M | 0.01% | 1641 |
|
|
2018
Q1 | $88.8M | Sell |
1,033,614
-4,876
| -0.5% | -$378K | ﹤0.01% | 1779 |
|
|
2017
Q4 | $76.9M | Buy |
1,038,490
+22,816
| +2% | +$1.53M | ﹤0.01% | 1849 |
|
|
2017
Q3 | $58.6M | Buy |
1,015,674
+35,948
| +4% | +$2.12M | ﹤0.01% | 1963 |
|
|
2017
Q2 | $62.8M | Buy |
979,726
+25,136
| +3% | +$1.55M | ﹤0.01% | 1902 |
|
|
2017
Q1 | $55M | Buy |
954,590
+36,655
| +4% | +$2.19M | ﹤0.01% | 1963 |
|
|
2016
Q4 | $56.2M | Sell |
917,935
-21,459
| -2% | -$1.4M | ﹤0.01% | 1911 |
|
|
2016
Q3 | $65M | Sell |
939,394
-118,044
| -11% | -$7.79M | ﹤0.01% | 1807 |
|
|
2016
Q2 | $58.9M | Sell |
1,057,438
-243,138
| -19% | -$14.7M | ﹤0.01% | 1826 |
|
|
2016
Q1 | $79M | Buy |
1,300,576
+22,090
| +2% | +$1.3M | 0.01% | 1629 |
|
|
2015
Q4 | $81.7M | Buy |
1,278,486
+20,418
| +2% | +$1.32M | 0.01% | 1599 |
|
|
2015
Q3 | $84.3M | Buy |
1,258,068
+69,514
| +6% | +$4.92M | 0.01% | 1559 |
|
|
2015
Q2 | $81.2M | Buy |
1,188,554
+204,352
| +21% | +$13M | 0.01% | 1661 |
|
|
2015
Q1 | $54.7M | Buy |
984,202
+134,826
| +16% | +$6.91M | ﹤0.01% | 1867 |
|
|
2014
Q4 | $43.6M | Buy |
849,376
+50,984
| +6% | +$2.5M | ﹤0.01% | 1900 |
|
|
2014
Q3 | $29.4M | Sell |
798,392
-85,228
| -10% | -$3.08M | ﹤0.01% | 2062 |
|
|
2014
Q2 | $34.5M | Sell |
883,620
-125,036
| -12% | -$4.64M | ﹤0.01% | 2006 |
|
|
2014
Q1 | $38M | Buy |
1,008,656
+14,200
| +1% | +$496K | ﹤0.01% | 1938 |
|
|
2013
Q4 | $37.6M | Buy |
994,456
+37,910
| +4% | +$1.45M | ﹤0.01% | 1917 |
|
|
2013
Q3 | $41.5M | Buy |
956,546
+86,448
| +10% | +$3.47M | ﹤0.01% | 1827 |
|
|
2013
Q2 | $31.5M | Buy |
+870,098
| New | +$26.4M | ﹤0.01% | 1892 |
|
Other funds holding USNA
NCM
Vanguard Group's USNA Position: Q4 2025 in Review
Vanguard Group reduced its Usana Health Sciences (USNA) stake by 13% in Q4 2025, selling an estimated $2.79M and leaving 934,316 shares worth $18.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2652.
Vanguard Group first reported a position in USNA in Q2 2013 and has held it in 51 quarters since. The position peaked at $159M in Q4 2018. 121 funds tracked by Wall St. Rank hold USNA as of Q4 2025.
- Vanguard Group held 934,316 shares of Usana Health Sciences worth $18.3M as of Q4 2025.
- Vanguard Group sold 134,716 Usana Health Sciences shares in Q4 2025, an estimated $2.79M.
- Usana Health Sciences made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2652 holding.
- Vanguard Group first reported a position in Usana Health Sciences in Q2 2013 and has held it in 51 quarters since.
- Vanguard Group's Usana Health Sciences position peaked at $159M in Q4 2018.
- 121 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.